Search

everythinglearnresearchcommunity

for

Search:↓

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Targeting lipid metabolism can help treat advanced, resistant cancers.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

Semaglutide does not significantly increase the risk of hair loss.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Oral isotretinoin, especially at higher doses for at least 3 months, is effective for treating folliculitis decalvans.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.